Unichem Laboratories Limited has informed the Exchange regarding 'Product recall'.
UNICHEMLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Unichem Laboratories' US subsidiary, Unichem Pharmaceuticals (USA), Inc., has voluntarily recalled Buspirone Hydrochloride Tablets (5mg strength) distributed in the USA. The recall was initiated due to an out-of-specification (OOS) assay result found at the 12-month long-term stability testing time point. The company has stated that no adverse events have been reported related to this recall. Unichem has emphasized its commitment to patient safety and product quality across its manufacturing and supply chain.
The voluntary recall indicates a quality concern but is limited in scope since no adverse events have been reported. The financial impact remains unclear as the company has not disclosed the quantity recalled or the revenue contribution of this product. This may raise investor concerns about the company's quality control systems.